The Australian Cancer Research Foundation (ACRF) will provide $2 million to fund the creation of the ACRF Facility for Innovative Cancer Drug Discovery at the Bio21 Institute, University of Melbourne.
The chief investigators, Professor Michael Parker and Dr David Ascher of Bio21, Professor Rick Pearson of the Peter MacCallum Cancer Centre and Professor John Silke of the Walter and Eliza Hall Institute, represent some of Victoria’s major cancer research institutions.
